The natural product industry is booming and showing no signs of slowing. Big brands are taking note by scooping up smaller, innovative companies that are disrupting consumer products by adding a natural twist. Michael Cammarata, Co-Founder and CEO of Schmidt's Naturals, shared why his company was such an attractive target for Unilever. Cammarata said Unilever was drawn to his brand due to its rapid growth and ability to go to market quickly. He said consumers have been the brands biggest advocate. The entrepreneur also added that the Unilever focuses on the founders and allows them to continue to operate the way they want. All-natural has been all the rage as consumers increasingly opt for chemical-free products. He says his brand is unique because they focused on competing with brands in the traditional space. He added consumers are realizing products with natural ingredients are delivering similar results as the initial products.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More